# Primary Resistance in HIV Patients in Colombia

> **NCT03957369** · — · COMPLETED · sponsor: **Fundacion REVIVA, Red de VIH del Valle del Cauca** · enrollment: 527 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DIAGNOSTIC_TEST:** HIV-1 plasma RNA Genotyping secuencing by Sanger technique
- **DIAGNOSTIC_TEST:** HIV-1 plasma RNA Genotyping secuencing by Ultra-deep sequencing technique

## Key facts

- **NCT ID:** NCT03957369
- **Lead sponsor:** Fundacion REVIVA, Red de VIH del Valle del Cauca
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-03
- **Primary completion:** 2023-11-30
- **Final completion:** 2024-04-01
- **Target enrollment:** 527 (ACTUAL)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03957369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03957369, "Primary Resistance in HIV Patients in Colombia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03957369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*